Skip to main content

Advertisement

Table 2 Clinical outcome of patients after two years of ACI. Lysholm score (65% cutoff) after two years was used to divide patients in success and failure group

From: In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes

Source Age-ranges Gender Defect (cm2) VAS KOOS Lysholm
Pre 2 yr Pre 2 yr Pre 2 yr
Success group (> 65% Lysholm)
 Donor 1 19–55 M 2.25 40 3 43.5 82.7 55 90
 Donor 2 M 3 40 12 68.5 82.1 69 90
 Donor 3 M 4.6 50 10 71.4 83.9 56 86
 Donor 4 M 9.75 62 10 62.5 76.9 52 83
 Donor 5 F 5.2 31 34 78 82.7 64 78
 Donor 6 F 3.6 51 14 68.3 73.8 59 74
 Donor 7 F 6 48 51 58.3 70.8 57 69
 Donor 8 M 21.5 17 4 72.6 84.8 50 69
 Donor 9 M 2.4 67 35 38.7 71.4 58 68
Failure group (< 65% Lysholm)
 Donor 10 31–52 F 1.82 50 69 32.1 54.8 56 62
 Donor 11 M 5 51 37 82.7 52.4 64 56
 Donor 12 M 3 30 56 36.3 47.6 56 49
 Donor 13 F 3.1 60 73 68.5 47.6 55 47
 Donor 14 M 1.2 74 76 44 35.7 41 38